Fig. 2From: Response to pembrolizumab in a heavily treated patient with metastatic ovarian carcinosarcomaObjective partial response in the right-posterior pectoral lymph node conglomerate. (Left) Before treatment with pembrolizumab. (Right) After four cycles of pembrolizumabBack to article page